Panvas-D
PANVAS-D is a combination tablet containing Pantoprazole, a proton pump inhibitor (PPI), and Domperidone, a prokinetic agent. This dual-action formulation is designed to provide relief from acid-related gastrointestinal disorders, improve gastric motility, and reduce symptoms such as heartburn, bloating, nausea, and regurgitation.
- Recommended Usage
Indications
- Gastroesophageal Reflux Disease (GERD): Reduces acid reflux and associated symptoms like heartburn, regurgitation, and chest discomfort.
- Dyspepsia (Indigestion): Alleviates bloating, nausea, and discomfort associated with impaired gastric motility.
- Erosive Esophagitis: Treats inflammation of the esophagus caused by acid reflux.
- Peptic Ulcers: Helps heal ulcers by reducing stomach acid and improving gastric motility.
- Delayed Gastric Emptying: Domperidone enhances gastric motility, helping alleviate nausea, bloating, and fullness.
- Nausea and Vomiting: Effective in controlling nausea and vomiting due to gastrointestinal disturbances.
Dosage and Administration
Route of Administration: Oral tablet.
Typical Dose for Adults: One tablet daily, typically 15-30 minutes before a meal, or as prescribed by a healthcare provider.
Administration: Swallow the tablet whole with water. Do not chew, crush, or split the tablet to maintain its effectiveness.
Duration of Therapy: The duration of use depends on the condition being treated and should be determined by a healthcare provider.
Precautions
Hypersensitivity: Avoid use in patients allergic to Pantoprazole, Domperidone, or any component of the formulation.
Pregnancy and Breastfeeding: Use during pregnancy and breastfeeding should only be considered if the benefits outweigh the risks, under the guidance of a healthcare provider.
Liver or Kidney Disease: Use with caution in patients with liver or kidney impairment. Dose adjustments may be needed.
Cardiac Conditions: Domperidone may increase the risk of QT prolongation; it should be used cautiously in patients with heart disease or those taking other drugs that prolong the QT interval.
Prolonged Use: Long-term use of PPIs like Pantoprazole may lead to vitamin B12 deficiency, magnesium deficiency, and an increased risk of bone fractures. Regular monitoring may be necessary.
Benefits
Dual Mechanism of Action: Pantoprazole provides acid suppression, while Domperidone enhances gastric motility and reduces nausea.
Comprehensive Relief: Treats both acid reflux and motility-related symptoms, offering broad symptom control.
Convenient Administration: Once-daily tablet, ensuring easy adherence to treatment.
Eases Bloating and Nausea: Domperidone helps reduce discomfort associated with delayed gastric emptying.
Well-Tolerated: Generally well-tolerated when taken as prescribed, with minimal side effects.
